SAN ANTONIO--(BUSINESS WIRE)--Jun 10, 2020--. bioAffinity Technologies, a privately held biotech company, today announced its test validation ...
News
- bioAffinity Technologies Validation Trial for Non-Invasive Lung Cancer Test Results in High ...
- What a Cancelled Gathering in Chicago Says About San Antonio's Future as a 'Convention City'
It's been much the same with the meetings of the ophthalmologists, the orthopedic surgeons, the dentists, and even the annual biotechnology event BIO ...
- Enzo Biochem: Fiscal 3Q Earnings Snapshot
On an adjusted basis, the 2019 fiscal third-quarter loss totaled $6.1 million, or 13 cents per share. The life sciences and biotechnology company posted ...
- US Presidential Scholar Award recognizes local student
“I'm going to Duke University next year to the School of Engineering for biomedical engineering,” Lloyd said. Just a few weeks ago, results were ...
- National coronavirus updates: Confirmed coronavirus cases worldwide rising faster than ever
The U.S. Biomedical Advanced Research and Development Authority, a part of the Department of Health and Human Services, is funding research on ...